Literature DB >> 2022256

Direct positive effect of epidermal growth factor on the cytoplasmic maturation of mouse and human oocytes.

K Das1, L E Stout, H C Hensleigh, G E Tagatz, W R Phipps, B S Leung.   

Abstract

OBJECTIVE: Immature mammalian oocytes cultured in vitro undergo inadequate cytoplasmic maturation and hence have a limited potential for fertilization. Our primary objective was to determine if the addition of epidermal growth factor (EGF) to the in vitro culture system would have a positive effect on oocyte cytoplasmic maturation.
DESIGN: We studied the effect of different EGF concentrations on both denuded and cumulus-enclosed mouse oocytes cultured in vitro. MAIN OUTCOME MEASURES: The percentage of oocytes undergoing germinal vesicle breakdown (GVBD) and polar body one formation over time as a function of EGF concentration was determined.
RESULTS: A dose-related positive effect of EGF on both GVBD and polar body one formation over time was observed for mouse oocytes. As well, a similar effect of EGF was seen on immature human oocytes that had not been stimulated with exogenous gonadotropins.
CONCLUSIONS: The use of EGF may allow for the performance of successful in vitro fertilization procedures using immature human oocytes retrieved during unstimulated cycles.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022256     DOI: 10.1016/s0015-0282(16)54313-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

1.  Treatment variables in relation to oocyte maturation: lessons from a clinical micromanipulation-assisted in vitro fertilization program.

Authors:  O M Avrech; G A Goldman; O Rufas; A Stein; S Amit; I Yoles; H Pinkas; B Fisch
Journal:  J Assist Reprod Genet       Date:  1997-07       Impact factor: 3.412

2.  Prediction of nuclear maturity from cumulus-coronal morphology: influence of embryologist experience.

Authors:  D G Hammitt; C H Syrop; B J Van Voorhis; D L Walker; T M Miller; K M Barud; C C Hood
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

3.  Ovarian brain-derived neurotrophic factor (BDNF) promotes the development of oocytes into preimplantation embryos.

Authors:  Kazuhiro Kawamura; Nanami Kawamura; Sabine M Mulders; Maarten D Sollewijn Gelpke; Aaron J W Hsueh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

4.  IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol.

Authors:  B Asimakopoulos; B Schöpper; A Dawson; G S Caglar; I Vakalopoulos; S Al-Hasani; K Diedrich; N Nikolettos
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 5.  New molecular markers for the evaluation of gamete quality.

Authors:  G Ruvolo; R R Fattouh; L Bosco; A M Brucculeri; E Cittadini
Journal:  J Assist Reprod Genet       Date:  2013-02       Impact factor: 3.412

Review 6.  Structural and functional changes linked to, and factors promoting, cytoplasmic maturation in mammalian oocytes.

Authors:  Masayasu Yamada; Yuuki Isaji
Journal:  Reprod Med Biol       Date:  2011-03-17

7.  Fibroblast growth factor induces primitive streak formation in rabbit pre-implantation embryos in vitro.

Authors:  M Hrabĕ de Angelis; C Kirchner
Journal:  Anat Embryol (Berl)       Date:  1993-03

8.  Human oocyte maturation is dependent on LH-stimulated accumulation of the epidermal growth factor-like growth factor, amphiregulin.

Authors:  A M Zamah; M Hsieh; J Chen; J L Vigne; M P Rosen; M I Cedars; M Conti
Journal:  Hum Reprod       Date:  2010-08-18       Impact factor: 6.918

9.  Preimplantation embryo development enhanced by epidermal growth factor.

Authors:  R P Buyalos; X Cai
Journal:  J Assist Reprod Genet       Date:  1994-01       Impact factor: 3.412

Review 10.  Embryological aspects of oocyte in vitro maturation.

Authors:  Mir Mehrdad Farsi; Nematollah Kamali; Mohsen Pourghasem
Journal:  Int J Mol Cell Med       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.